{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:00:29Z","timestamp":1793361629706,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T00:00:00Z","timestamp":1685750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T00:00:00Z","timestamp":1685750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00432-023-04943-4","type":"journal-article","created":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T16:01:35Z","timestamp":1685808095000},"page":"10241-10253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Combined detection of SDC2\/ADHFE1\/PPP2R5C methylation in stool DNA for colorectal cancer screening"],"prefix":"10.1007","volume":"149","author":[{"given":"Ben","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanglong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longbo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,3]]},"reference":[{"key":"4943_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/XCS.0000000000000768","author":"CJ Allen","year":"2023","unstructured":"Allen CJ et al (2023) Comprehensive cost implications of commercially available noninvasive colorectal cancer screening modalities. J Am Coll Surg. https:\/\/doi.org\/10.1097\/XCS.0000000000000768","journal-title":"J Am Coll Surg"},{"issue":"9726","key":"4943_CR2","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/S0140-6736(10)60551-X","volume":"375","author":"WS Atkin","year":"2010","unstructured":"Atkin WS et al (2010) Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 375(9726):1624\u20131633. https:\/\/doi.org\/10.1016\/S0140-6736(10)60551-X","journal-title":"Lancet"},{"key":"4943_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1146\/annurev-med-103018-123125","volume":"71","author":"JM Carethers","year":"2020","unstructured":"Carethers JM (2020) Fecal DNA testing for colorectal cancer screening. Annu Rev Med 71:59\u201369. https:\/\/doi.org\/10.1146\/annurev-med-103018-123125","journal-title":"Annu Rev Med"},{"issue":"7","key":"4943_CR4","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1158\/1940-6207.CAPR-12-0501","volume":"6","author":"FJ Carmona","year":"2013","unstructured":"Carmona FJ et al (2013) DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer. Cancer Prev Res (phila) 6(7):656\u2013665. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-12-0501","journal-title":"Cancer Prev Res (phila)"},{"issue":"2","key":"4943_CR5","first-page":"198","volume":"105","author":"KT Clebak","year":"2022","unstructured":"Clebak KT, Nickolich S, Mendez-Miller M (2022) Multitarget stool DNA testing (Cologuard) for colorectal cancer screening. Am Fam Physician 105(2):198\u2013200","journal-title":"Am Fam Physician"},{"issue":"4","key":"4943_CR6","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3748\/wjg.v20.i4.943","volume":"20","author":"F Coppede","year":"2014","unstructured":"Coppede F et al (2014) Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer. World J Gastroenterol 20(4):943\u2013956. https:\/\/doi.org\/10.3748\/wjg.v20.i4.943","journal-title":"World J Gastroenterol"},{"issue":"15","key":"4943_CR7","first-page":"3455","volume":"58","author":"JM Cunningham","year":"1998","unstructured":"Cunningham JM et al (1998) Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Can Res 58(15):3455\u20133460","journal-title":"Can Res"},{"issue":"19","key":"4943_CR8","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1001\/jama.2021.6238","volume":"325","author":"KW Davidson","year":"2021","unstructured":"Davidson KW et al (2021) Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA 325(19):1965\u20131977. https:\/\/doi.org\/10.1001\/jama.2021.6238","journal-title":"JAMA"},{"issue":"10207","key":"4943_CR9","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/s0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E et al (2019) Colorectal cancer. The Lancet 394(10207):1467\u20131480. https:\/\/doi.org\/10.1016\/s0140-6736(19)32319-0","journal-title":"The Lancet"},{"issue":"9","key":"4943_CR10","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1136\/gutjnl-2014-308075","volume":"64","author":"BT Dickinson","year":"2015","unstructured":"Dickinson BT et al (2015) Molecular markers for colorectal cancer screening. Gut 64(9):1485\u20131494. https:\/\/doi.org\/10.1136\/gutjnl-2014-308075","journal-title":"Gut"},{"issue":"1","key":"4943_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13148-020-00851-3","volume":"12","author":"J Fan","year":"2020","unstructured":"Fan J et al (2020) Genome-wide DNA methylation profiles of low- and high-grade adenoma reveals potential biomarkers for early detection of colorectal carcinoma. Clin Epigenetics 12(1):56. https:\/\/doi.org\/10.1186\/s13148-020-00851-3","journal-title":"Clin Epigenetics"},{"issue":"1","key":"4943_CR12","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1038\/s41598-018-21048-y","volume":"8","author":"Y Gao","year":"2018","unstructured":"Gao Y et al (2018) Evaluation of serum CEA, CA19-9, CA72-4, CA125 and ferritin as diagnostic markers and factors of clinical parameters for colorectal cancer. Sci Rep 8(1):2732. https:\/\/doi.org\/10.1038\/s41598-018-21048-y","journal-title":"Sci Rep"},{"issue":"20","key":"4943_CR13","first-page":"4531","volume":"55","author":"M Gonzalez-Zulueta","year":"1995","unstructured":"Gonzalez-Zulueta M et al (1995) Methylation of the 5\u2019 CpG island of the p16\/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Can Res 55(20):4531\u20134535","journal-title":"Can Res"},{"key":"4943_CR14","doi-asserted-by":"crossref","unstructured":"Gress D, Edge S, Greene F, Washington M, Asare E, Brierley J et al (2017) AJCC cancer staging manual-8th Edition. American College of Surgeons, Principles of cancer staging - American Joint Committee on Cancer","DOI":"10.1007\/978-3-319-40618-3_1"},{"issue":"3","key":"4943_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.14309\/ajg.0000000000000544","volume":"115","author":"S Gupta","year":"2020","unstructured":"Gupta S et al (2020) Recommendations for follow-up after colonoscopy and polypectomy: a consensus update by the US multi-society task force on colorectal cancer. Am J Gastroenterol 115(3):415\u2013434. https:\/\/doi.org\/10.14309\/ajg.0000000000000544","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"4943_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13148-019-0642-0","volume":"11","author":"YD Han","year":"2019","unstructured":"Han YD et al (2019) Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA. Clin Epigenetics 11(1):51. https:\/\/doi.org\/10.1186\/s13148-019-0642-0","journal-title":"Clin Epigenetics"},{"key":"4943_CR17","doi-asserted-by":"publisher","first-page":"8105","DOI":"10.2147\/OTT.S223423","volume":"12","author":"YH Hu","year":"2019","unstructured":"Hu YH et al (2019) Hypermethylation Of ADHFE1 promotes the proliferation of colorectal cancer cell via modulating cell cycle progression. Onco Targets Ther 12:8105\u20138115. https:\/\/doi.org\/10.2147\/OTT.S223423","journal-title":"Onco Targets Ther"},{"key":"4943_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109630","volume":"121","author":"R Hua","year":"2020","unstructured":"Hua R et al (2020) Syndecan-2 in colorectal cancer plays oncogenic role via epithelial-mesenchymal transition and MAPK pathway. Biomed Pharmacother 121:109630. https:\/\/doi.org\/10.1016\/j.biopha.2019.109630","journal-title":"Biomed Pharmacother"},{"issue":"14","key":"4943_CR19","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1311194","volume":"370","author":"TF Imperiale","year":"2014","unstructured":"Imperiale TF et al (2014) Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 370(14):1287\u20131297. https:\/\/doi.org\/10.1056\/NEJMoa1311194","journal-title":"N Engl J Med"},{"issue":"2","key":"4943_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41575-019-0230-y","volume":"17","author":"G Jung","year":"2020","unstructured":"Jung G et al (2020) Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nat Rev Gastroenterol Hepatol 17(2):111\u2013130. https:\/\/doi.org\/10.1038\/s41575-019-0230-y","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"4943_CR21","first-page":"808","volume":"57","author":"MF Kane","year":"1997","unstructured":"Kane MF et al (1997) Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Can Res 57(5):808\u2013811","journal-title":"Can Res"},{"issue":"2","key":"4943_CR22","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1053\/j.gastro.2019.06.043","volume":"158","author":"U Ladabaum","year":"2020","unstructured":"Ladabaum U et al (2020) Strategies for colorectal cancer screening. Gastroenterology 158(2):418\u2013432. https:\/\/doi.org\/10.1053\/j.gastro.2019.06.043","journal-title":"Gastroenterology"},{"issue":"4","key":"4943_CR23","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.cgh.2017.07.011","volume":"16","author":"I Lansdorp-Vogelaar","year":"2018","unstructured":"Lansdorp-Vogelaar I et al (2018) Cost-effectiveness of High-performance biomarker tests vs fecal immunochemical test for noninvasive colorectal cancer screening. Clin Gastroenterol Hepatol 16(4):504-512.e11. https:\/\/doi.org\/10.1016\/j.cgh.2017.07.011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"4943_CR24","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nrgastro.2011.173","volume":"8","author":"VV Lao","year":"2011","unstructured":"Lao VV, Grady WM (2011) Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol 8(12):686\u2013700. https:\/\/doi.org\/10.1038\/nrgastro.2011.173","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"4943_CR25","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3748\/wjg.v29.i4.706","volume":"29","author":"HN Liu","year":"2023","unstructured":"Liu HN et al (2023) Diagnostic and economic value of carcinoembryonic antigen, carbohydrate antigen 19\u20139, and carbohydrate antigen 72\u20134 in gastrointestinal cancers. World J Gastroenterol 29(4):706\u2013730. https:\/\/doi.org\/10.3748\/wjg.v29.i4.706","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4943_CR26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13148-022-01273-z","volume":"14","author":"M Massen","year":"2022","unstructured":"Massen M et al (2022) Technical considerations in PCR-based assay design for diagnostic DNA methylation cancer biomarkers. Clin Epigenetics 14(1):56. https:\/\/doi.org\/10.1186\/s13148-022-01273-z","journal-title":"Clin Epigenetics"},{"issue":"2","key":"4943_CR27","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.gastro.2005.05.056","volume":"129","author":"T Morikawa","year":"2005","unstructured":"Morikawa T et al (2005) A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 129(2):422\u2013428. https:\/\/doi.org\/10.1016\/j.gastro.2005.05.056","journal-title":"Gastroenterology"},{"issue":"9417","key":"4943_CR28","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/S0140-6736(04)16002-9","volume":"363","author":"HM M\u00fcller","year":"2004","unstructured":"M\u00fcller HM et al (2004) Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet (london, England) 363(9417):1283\u20131285","journal-title":"Lancet (london, England)"},{"issue":"9","key":"4943_CR29","doi-asserted-by":"publisher","first-page":"921","DOI":"10.4161\/epi.25577","volume":"8","author":"VA Naumov","year":"2013","unstructured":"Naumov VA et al (2013) Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics 8(9):921\u2013934. https:\/\/doi.org\/10.4161\/epi.25577","journal-title":"Epigenetics"},{"key":"4943_CR30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13148-017-0426-3","volume":"9","author":"TJ Oh","year":"2017","unstructured":"Oh TJ et al (2017) Feasibility of quantifying methylation in stool DNA for early detection of colorectal cancer. Clin Epigenetics 9:126. https:\/\/doi.org\/10.1186\/s13148-017-0426-3","journal-title":"Clin Epigenetics"},{"issue":"12","key":"4943_CR31","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nrgastro.2011.205","volume":"8","author":"N Pawa","year":"2011","unstructured":"Pawa N, Arulampalam T, Norton JD (2011) Screening for colorectal cancer: established and emerging modalities. Nat Rev Gastroenterol Hepatol 8(12):711\u2013722. https:\/\/doi.org\/10.1038\/nrgastro.2011.205","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"4943_CR32","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1038\/ajg.2017.285","volume":"112","author":"JA Shapiro","year":"2017","unstructured":"Shapiro JA et al (2017) A comparison of fecal immunochemical and high-sensitivity guaiac tests for colorectal cancer screening. Am J Gastroenterol 112(11):1728\u20131735. https:\/\/doi.org\/10.1038\/ajg.2017.285","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"4943_CR33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13148-023-01443-7","volume":"15","author":"Y Shen","year":"2023","unstructured":"Shen Y et al (2023) Novel DNA methylation biomarkers in stool and blood for early detection of colorectal cancer and precancerous lesions. Clin Epigenetics 15(1):26. https:\/\/doi.org\/10.1186\/s13148-023-01443-7","journal-title":"Clin Epigenetics"},{"issue":"3","key":"4943_CR34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3322\/caac.21601","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL et al (2020) Colorectal cancer statistics, 2020. CA Cancer J Clin 70(3):145\u2013164. https:\/\/doi.org\/10.3322\/caac.21601","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4943_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3322\/caac.21261","volume":"65","author":"RA Smith","year":"2015","unstructured":"Smith RA et al (2015) Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening. CA Cancer J Clin 65(1):30\u201354. https:\/\/doi.org\/10.3322\/caac.21261","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"4943_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"4943_CR37","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1471-2407-13-142","volume":"13","author":"CH Tae","year":"2013","unstructured":"Tae CH et al (2013) Alcohol dehydrogenase, iron containing, 1 promoter hypermethylation associated with colorectal cancer differentiation. BMC Cancer 13:142. https:\/\/doi.org\/10.1186\/1471-2407-13-142","journal-title":"BMC Cancer"},{"issue":"3","key":"4943_CR38","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/gut.48.3.367","volume":"48","author":"JM Wheeler","year":"2001","unstructured":"Wheeler JM et al (2001) Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer. Gut 48(3):367\u2013371","journal-title":"Gut"},{"issue":"3","key":"4943_CR39","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3109\/10409238.2016.1143913","volume":"51","author":"N Wlodarchak","year":"2016","unstructured":"Wlodarchak N, Xing Y (2016) PP2A as a master regulator of the cell cycle. Crit Rev Biochem Mol Biol 51(3):162\u2013184. https:\/\/doi.org\/10.3109\/10409238.2016.1143913","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"4","key":"4943_CR40","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3322\/caac.21457","volume":"68","author":"AMD Wolf","year":"2018","unstructured":"Wolf AMD et al (2018) Colorectal cancer screening for average-risk adults: 2018 guideline update from the American cancer society. CA Cancer J Clin 68(4):250\u2013281. https:\/\/doi.org\/10.3322\/caac.21457","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4943_CR41","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1158\/1078-0432.CCR-20-2589","volume":"27","author":"H Xie","year":"2021","unstructured":"Xie H et al (2021) Novel methylated DNA markers in the surveillance of colorectal cancer recurrence. Clin Cancer Res 27(1):141\u2013149. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-2589","journal-title":"Clin Cancer Res"},{"key":"4943_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.706754","volume":"8","author":"L Zhang","year":"2021","unstructured":"Zhang L et al (2021) Methylation of SDC2\/TFPI2 and its diagnostic value in colorectal tumorous lesions. Front Mol Biosci 8:706754. https:\/\/doi.org\/10.3389\/fmolb.2021.706754","journal-title":"Front Mol Biosci"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04943-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-04943-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04943-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T13:15:18Z","timestamp":1691846118000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-04943-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,3]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["4943"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-04943-4","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,3]]},"assertion":[{"value":"4 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by The Affiliated Hospital of Qingdao University\u2019s Ethics Committee (No. QYFYKYLL 965311920) and preregistered it with the Chinese Clinical Trial Registry (, Registration ID: ChiCTR2100046662). The informed consent was obtained from all subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}